Blake Insomnia Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$1.53 |
Market Cap |
$46.56 M |
Shares Outstanding |
25.03 M |
Public Float |
15 K |
Address |
244 5th Avenue New York New York 10001 United States |
Employees | - |
Website | http://www.blakeinsomnia.com |
Updated | 07/08/2019 |
Blake Insomnia Therapeutics, Inc. operates as a pharmaceutical company, which provides insomnia remedy. The firm has developed Zleepax, which is a sleep aid with beta blockers as the major active agent. The company was founded by Briger Jan Olsen on August 11, 2012 and is headquartered in New York, NY. |